Skip to the page

Data / Form D filings / Secretome Therapeutics, Inc.

Secretome Therapeutics, Inc.: Form D filing

Secretome Therapeutics, Inc., a biotechnology company in Dallas, TX, filed a Form D with the SEC in 2023. The latest, on February 2, 2023, reports $6.9 million sold of a $10.9 million offering to 48 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
3060 PEGASUS PARK DR, BUILDING 6, Dallas, TX, 75247
Phone
(646) 526-9628
Industry
Biotechnology
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2018
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1961833

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Feb 2, 2023New notice$10,888,098$6,854,247$4,033,85148Nov 23, 2022sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
ANGELA SHENDirector
HENRIK RASMUSSENDirector
VINEET JINDALExecutive Officer, Director
SUNJAY KAUSHALDirector
WILLIAM NILANDDirector

Other biotechnology companies in Texas that filed recently

Every Form D from the week of Jan 30, 2023 · All recent filings in Texas · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what Secretome Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.